San Diego, CA (PRWEB) February 06, 2013
AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on Yasmin and Yaz lawsuits.
On January 14th, 2013, the US Judicial Panel on Multi-District Litigation (MDL) informed that there are 9,455 actions currently pending in the Yasmin/Yaz (Drospirenone) Multi-District Litigation (MDL 2100, US District Court, Southern District of Illinois). Yasmin, which was approved by the FDA in 2001, and its sister drug Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. Yasmin and Yaz are manufactured by Bayer Healthcare Pharmaceuticals.
According to court documents, on December 11th, 2012, five plaintiffs filed a lawsuit in Illinois Southern District Court (case no. 3:2012cv11630) alleging they suffered serious medical issues from their use of Yasmin and Yaz. In the lawsuit, the estate of a woman alleges she died after having a stroke having taken Yasmin or Yaz for slightly over a month. Another plaintiff claims she developed severe complications with her gallbladder from her use of the drugs that required its removal. The other three plaintiffs claim they suffer from Deep Vein Thrombosis (DVT), blood clots and heart blockage caused by Yasmin and Yaz.
Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Yaz severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Yasmin and Yaz lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
On April 10th, 2012, the US FDA announced that, based on the review of recent observational (epidemiologic) studies, the agency has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills. The FDA added information about the studies to the labels of drospirenone-containing birth control pills, including Yasmin and Yaz.
AttorneyOne.com has further information on Yasmin and Yaz lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/2/prweb10392372.htm